High, stable and homogenous CD20 expression for efficient rituximab-induced elimination of CD20+ alloreactive donor T cells in the novel CD20/Rituximab 'suicide' system

被引：1
|
作者：
van Meerten, T [1 ]
Claessen, MJ [1 ]
Hagenbeek, A [1 ]
Ebeling, S [1 ]
机构：
[1] Univ Utrecht, Med Ctr, Jordan Lab Hematooncol, Utrecht, Netherlands
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.1750.1750
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1750
引用
收藏
页码：485A / 485A
页数：1
相关论文
共 50 条
  • [1] The CD20/αCD20 'suicide' system:: novel vectors with improved safety and expression profiles and efficient elimination of CD20-transgenic T cells
    van Meerten, T
    Claessen, MJ
    Hagenbeek, A
    Ebeling, SB
    [J]. GENE THERAPY, 2006, 13 (09) : 789 - 797
  • [2] The CD20/αCD20 ‘suicide’ system: novel vectors with improved safety and expression profiles and efficient elimination of CD20-transgenic T cells
    T van Meerten
    M-J Claessen
    A Hagenbeek
    S B Ebeling
    [J]. Gene Therapy, 2006, 13 : 789 - 797
  • [3] Influence of cytokines on CD20 expression and Rituximab-induced CDC on MC/CAR myeloma cells
    Umeda, M
    Kuraishi, Y
    Nakai, S
    Furukawa, K
    Akahane, S
    Tsuru, H
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 99P - 99P
  • [4] Rituximab in CD20 positive multiple myeloma
    J M Bergua
    C Cabrera
    E G Arteta
    J Prieto
    [J]. Leukemia, 2008, 22 : 1082 - 1083
  • [5] Rituximab in CD20 positive multiple myeloma
    P Moreau
    L Voillat
    L Benboukher
    C Mathiot
    C Dumontet
    N Robillard
    O Hérault
    F Garnache
    R Garand
    N Varoqueaux
    H Avet-Loiseau
    J L Harousseau
    R Bataille
    [J]. Leukemia, 2007, 21 : 835 - 836
  • [6] Transient downmodulation of CD20 by rituximab.
    Jilani, I
    O'Brien, S
    Manshouri, T
    Thomas, DA
    Thomazy, VA
    Imam, M
    Naeem, S
    Verstovsek, S
    Kantarjian, H
    Giles, F
    Keating, M
    Albitar, M
    [J]. BLOOD, 2002, 100 (11) : 804A - 804A
  • [7] Rituximab in CD20 positive multiple myeloma
    Moreau, P.
    Voillat, L.
    Benboukher, L.
    Mathiot, C.
    Dumontet, C.
    Robillard, N.
    Herault, O.
    Garnache, F.
    Garand, R.
    Varoqueaux, N.
    Avet-Loiseau, H.
    Harousseau, J. L.
    Bataille, R.
    [J]. LEUKEMIA, 2007, 21 (04) : 835 - +
  • [8] Rituximab in CD20 positive multiple myeloma
    Bergua, J. M.
    Cabrera, C.
    Arteta, E. G.
    Prieto, J.
    [J]. LEUKEMIA, 2008, 22 (05) : 1082 - 1083
  • [9] Loss of CD20 expression on CLL cells following treatment with rituximab
    Poirot, Brigitte
    Chedani, Hicham
    Abbed, Karim
    Tertian, Gerard
    Raphael, Martine
    Besson, Caroline
    [J]. HEMATOLOGIE, 2010, 16 (01): : 92 - 95
  • [10] Restoration of rituximab sensitivity in CD20 negative B-Cell lymphoma, cells; Epigenetic change of CD20 expression after treatment of rituximab.
    Tomita, Akihiro
    Hiraga, Junji
    Kiyoi, Hitoshi
    Kinoshita, Tomohiro
    Naoe, Tornoki
    [J]. BLOOD, 2006, 108 (11) : 155B - 155B
12345